Gastroenterology Review (Jan 2022)
Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and metanalysis
Abstract
No abstracts available.Keywords
Gastroenterology Review (Jan 2022)